The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...
For instance, solutions like eWizard flag errors, from missing references to inappropriate images or typos. And when ...
John Hult/South Dakota Searchlight South Dakota’s top law enforcement official wants lawmakers to stiffen penalties for ...
Researchers in China have unveiled a new AI framework that could accelerate the discovery of new medicines. DrugCLIP can scan ...
Eureka Therapeutics, Inc., a clinical-stage biotechnology company advancing next-generation T-cell therapies for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
SAFARI capsule technology offers a novel solution for medication adherence, using a dissolvable Faraday cage to verify ...
ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of 212Pb alpha radioligand ...
As the debate rages on, one thing is clear – the people of Malawi deserve transparency and accountability in the management of their resources. It is time for the government to take a hard stance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback